Having just received European CE mark certification for its Galen AI cancer diagnostic software (see here), Israel’s Ibex Medical has now been awarded “Breakthrough” designation by the US FDA. This will help fast-track clinical review and regulatory approval of its … Continue reading →

Israel’s Ibex Medical Analytics (see here previously) has received Europe’s CE Mark for its Galen Breast image analysis solution to help pathologists detect various types of cancer. It follows successful trials in Israel and France. https://www.calcalistech.com/ctech/articles/0,7340,L-3908568,00.html

The CorePlus pathology lab in Carolina Puerto Rico is the first in the Americas to detect prostate cancer using the AI-based software from Israel’s Ibex Medical Analytics (reported here previously). The system is already in use in the UK and … Continue reading →

Another instance of Israeli technology saving British lives. Israel’s Ibex Medical (reported here previously) is helping the UK’s National Health System (NHS) diagnose cancer from biopsies.  Ibex, has teamed up with UK’s LDPath to reduce pathology pressures on 24 different … Continue reading →

Israel’s Ibex Medical (see here) has deployed its Second Read cancer diagnostic system at Israel’s Maccabi  Health company. It is the first Artificial Intelligence-powered lab for diagnosis of breast cancer biopsies. https://ibex-ai.com/press/the-ibex-second-read-system-for-breast-is-now-deployed-at-maccabis-pathology-institute-making-it-the-first-lab-in-the-world-to-implement-ai-powered-cancer-diagnostics-for-breast-bio/

Israel’s Ibex Medical Analytics develops a diagnostic system that uses computer vision, machine learning, and electronic medical records to confirm cancer diagnoses of tissue biopsies. Ibex’s technology helps minimize the risk of misdiagnosis. Ibex has just received $11 million of … Continue reading →